Login / Signup

Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial.

Byung-Kun KimSoo Jin ChoJeong Hee HanGrazia Dell'AgnelloTommaso PanniManho KimKyungmi OhHeui Soo MoonMin Kyung Chu
Published in: Journal of clinical neurology (Seoul, Korea) (2023)
Galcanezumab treatment demonstrated efficacy and a favorable safety and tolerability profile in South Korean patients with EM.
Keyphrases
  • clinical trial
  • end stage renal disease
  • newly diagnosed
  • open label
  • randomized controlled trial
  • peritoneal dialysis
  • double blind
  • replacement therapy
  • phase iii